Solvonis Therapeutics: US Ketamine patent targets behavioral addictions

By Proactive Investors / November 09, 2026 / www.youtube.com / Article Link


Solvonis Therapeutics CEO Anthony Tennyson discusses a significant US patent allowance covering ketamine-based treatments ...

Recent News

Most major producers and TSXV gold have major gains
November 09, 2026 / www.canadianminingreport.com

Gold stocks rebound as metal price jumps
November 09, 2026 / www.canadianminingreport.com

Big Gold Q3/26 strong results continue
November 02, 2026 / www.canadianminingreport.com

Gold stocks decline as major sector rotation continues
November 02, 2026 / www.canadianminingreport.com

Gold stocks slump in global sector rotation
October 26, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok